New stent aims to tackle tough heart blockages
NCT ID NCT05658250
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a special drug-coated stent called Cre8 in 300 people with long blockages (at least 30 mm) in their heart arteries. The stent releases a medicine to help keep the artery open. Researchers are watching to see if it is safe and effective, looking for problems like heart attacks or the need for another procedure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CRE8 polymer-free amphilimus-eluting stent
What this could lead to
If successful, this could offer a better treatment option for people with long blockages in heart arteries, potentially reducing the need for repeat procedures.
What could go wrong
This is an observational study, not a randomized trial, so results may be less definitive. The stent may still carry risks like blood clots or re-narrowing of the artery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Yongin Severance Hospital
Yongin, Gyeonggi-do, 16995, South Korea